Phosphoenolpyruvate carboxykinase (PEPCK) is a key enzyme in gluconeogenesis, catalyzing the decarboxylation of oxaloacetate to phosphoenolpyruvate. In eukaryotes, there are two isozymes present either in the cytosol (PEPCK-C, PCK1) or in the mitochondria (PEPCK-M, PCK2). PCK2 is highly expressed in pancreatic β-cells, where it contributes to the regulation of the TCA cycle flux by coupling it to mitochondria GDP recycling. This flux has been shown to regulate glucose stimulated insulin secretion (GSIS) [1].
In order to obtain high purity and efficacy compounds, we synthetized, through lineal synthesis, a group of C-8 modified 3-alkyl-1,8-dibenzylxanthines, starting from 6-aminouracil. These compounds were described as potent PEPCK-C inhibitors by Roche [2]. Structural and docking analysis of both PEPCK isoforms showed that both enzymes are structurally very close and might be inhibited by the same family of inhibitors.
The lead inhibitor (INH-2) was compared with 3-mecaptopicolinic acid, a classic PCK1 inhibitor, in a kinetic assay, and the results confirmed the cross-inhibitory capacity between PCK1/PCK2 and their increased potency as inhibitors. Moreover, we studied PCK2 target engagement of our candidates through cellular thermal shift assays (CETSA).
INH-2 successfully inhibits GSIS in INS-1 cell line through PEPCK-M inhibition, validating the cross-inhibition between PEPCK-C and PEPCK-M. Furthermore, this compound inhibited insulin secretion In vivo, on an impaired glucose tolerance test (IGTT) in mice.
References
- Foley, L.H.; Wang, P.; Dunten, P.; Ramsey, G.; Gubler, M.; Wertheimer, S.J. X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines. Bioorg. Med. Chem. Lett. 2003, 13, 3871. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mendez-Lucas, A.; Hyrossova, P.; Novellasdemunt, L.; Viñals, F.; Perales, J.C. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J. Biol. Chem. 2015, 289, 22090. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).